Related Experiment Video
Updated: Apr 4, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Factors Associated With Discharge After Initial Emergency Treatment of Pediatric Migraine
Bhooma R Aravamuthan1, Soe Soe Mar, Kristine G Williams
1From the *St. Louis Children's Hospital; and Department of †Neurology, and ‡Pediatrics Washington University in St. Louis, St. Louis, MO.
Insights
Pediatric emergency department migraine treatment effectiveness varies. Higher discharge rates were seen with intravenous medications, particularly ketorolac and antiemetics, compared to oral or intranasal options.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Pharmacology
- Pain Management
Background:
- Migraine treatment protocols in pediatric emergency departments (EDs) show significant variability.
- Identifying factors that predict successful discharge after initial treatment is crucial for optimizing care.
Purpose of the Study:
- To examine patient characteristics and initial treatments associated with discharge after only initial emergency department migraine treatment.
- To inform evidence-based guidelines for pediatric migraine management in the ED.
Main Methods:
- Retrospective chart analysis of 700 pediatric patients (6-18 years) diagnosed with migraine between 2008-2011.
- Generalized linear models and receiver operating characteristic curves were used to analyze associations between treatments and discharge rates.
Main Results:
- Intravenous (IV) medications, especially ketorolac with an antiemetic, were associated with higher discharge rates than oral/intranasal (PO/IN) medications.
- Ibuprofen alone was linked to lower discharge rates compared to other PO/IN regimens.
- Arrival pain score was a significant predictor of discharge, with different thresholds for ibuprofen versus other PO/IN or IV treatments.
Conclusions:
- Arrival pain scores can guide the selection of initial migraine treatments in pediatric EDs.
- Consideration of PO/IN regimens with triptans or antiemetics, and IV ketorolac with an antiemetic, may improve discharge rates after initial treatment.
Objective:
Migraine treatment varies widely in the pediatric emergency department (ED). Factors associated with discharge after only initial emergency treatment were examined.
Methods:
A retrospective chart analysis was conducted on patients 6 to 18 years old who presented to the St. Louis Children's Hospital ED between January 1, 2008, and December 31, 2011, with a discharge diagnosis of migraine (n = 700 visits). Associations between patient characteristics, initial treatments, and rates of discharge after only initial treatment were examined using a generalized linear model and receiver operating characteristic curves.
Results:
If exclusively oral or intranasal (PO/IN) medications were given initially (n = 285), ibuprofen alone was associated with lower discharge rates compared with other PO/IN medication regimens (P < 0.05). The only other variable associated with discharge was arrival pain score (P < 0.05). When ibuprofen alone was administered, pain scores equal to or lower than 5/10 were associated with the greatest sensitivity and specificity for discharge. With administration of other PO/IN regimens, pain scores equal to or lower than 8/10 were associated with the greatest sensitivity and specificity for discharge. If intravenous (IV) medications were given initially (n = 415), ketorolac given with an antinausea medication was associated with higher discharge rates compared with independent administration of these medications (P < 0.05). Intravenous medications were associated with higher discharge rates compared with PO/IN medications (P < 0.001).
Conclusions:
Arrival pain score may be used to help select initial migraine treatment in the pediatric ED. Initial use of PO/IN regimens including triptans or an antiemetic and concurrent administration of IV ketorolac with an antiemetic may be associated with higher rates of discharge after initial treatment alone.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:

